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Immunoprecipitation (IP) and coimmunoprecipitation (co-IP) are key techniques for studying protein-protein interactions. These
methods utilizeimmobilized proteinAorproteinGtoisolateantibody-boundtargetantigens.Themaindisadvantage oftraditional
immunoprecipitation and coimmunoprecipitation is that the conditions used to elute the precipitated antigen also release the an-
tibody, contaminating the antigen and destroying the antibody support. To overcome these problems, we describe two methods to
generate a reusable antibody support by cross-linking the antibody to immobilized protein A or protein G, or by coupling it directly
to the resin. Our studies have demonstrated that the immobilization eﬃciency for the antibody coupling method was similar for
several species of antibody. Furthermore, we illustrate that using both methods of antibody immobilization yields IP and co-IP
results similar to traditional protocols but eliminates the antibody heavy and light chains contamination.
INTRODUCTION
Immunoprecipitation (IP) is a powerful immuno-
chemical technique that has been used to study antigen
characteristics such as antigen presence and quantity, rel-
ative molecular weight, rate of synthesis or degradation,
posttranslational modiﬁcations, and interactions with
proteins, nucleic acids, or ligands [1, 2, 3]. The IP proce-
dure involves extracting antigens from cells in an appro-
priate lysis buﬀer, incubating the lysate with antibody to
allow formation of immune complexes, and precipitating
thosecomplexeswithimmobilizedproteinAorproteinG.
Coimmunoprecipitation (co-IP) is a key technique
used to study protein-protein interactions [4]. Co-IP has
been widely used to study receptor-ligand interactions
[5], enzyme-substrate interactions [6], and interactions
of subunits within a protein complex [7]. Co-IP of cell
or tissue extract is also used to conﬁrm yeast two-hybrid
screening results [8, 9, 10]. Typically, an antibody speciﬁc
for one protein is incubated with a cell lysate or a pro-
tein mixture to form an immune complex with the target
protein (antigen). The target protein may be interacting
with one or other more proteins to form a protein com-
plex (co-complex). The entire co-complex is then precip-
itated using immobilized protein A or protein G.
Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by staining, autoradiog-
raphy, or Western blot analysis is typically used to detect
the interacting partners. If the antigen or its interaction
partner(s) and the antibody heavy and light chains have
similar relative molecular weights then, under reducing
conditions, they will comigrate, making analysis of the
IP results problematic. Several alternatives are currently
used to circumvent this problem. One of these methods
is to eliminate the reducing agent in the Laemmli buﬀer
to cause the whole antibody molecule to migrate at the
top of the gel, thus separating it from most proteins [11].
This technique, however, utilizes milder sample denatur-
ing conditions which may not disrupt strong interactions
within protein complexes and, therefore, may not be use-
ful for co-IP experiments. A second alternative is to probe
Western blots with biotinylated primary antibodies [12].
This method is generally less sensitive but must be exer-
cised when the antibodies used for IP and immunoblot-
ting have been generated in the same animal species. In
this paper, we present two quick and easy IP and co-IP
methods (seize technology) to eliminate antibody con-
tamination in precipitated proteins: the antibody cross-
linking method and the antibody coupling method (Seize
Technology is a trademark of Pierce Biotechnology, Inc,
Rockford, Ill—Scheme 1) that improve protein-protein
interaction detection. The ﬁrst approach uses a chemi-
cal cross-linker, disuccinimidyl suberate (DSS), to attach
the Fc portion of an antibody to immobilized protein
A or protein G. This novel procedure combines cross-
linking and aﬃnity chromatography to generate an ori-
ented antibody-protein A or protein G support. The sec-
ond method couples the antibody directly onto an acti-
vatedsupportvialysineresidues.Thiscouplingprocedure
eliminates the need for protein A or protein G and oﬀers
universal coupling of all antibody species and subclasses;
e v e nc h i c k e nI g Ya n dm o u s eI g G 2a can be coupled equally
well. Moreover, the antibody supports generated by both
methods are reusable.292 M. Walid Qoronﬂeh et al 2003:5 (2003)
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Scheme 1. Diagram of the antibody bioconjugation chemistry. (a) Description of the antibody cross-linked method. (b) Explanation
of the antibody-coupled method.
We have compared the traditional (non-cross-linked),
the antibody cross-linked, and the antibody-coupled IP
techniques. The traditional IP method gave higher recov-
ery of target protein but contained strong contamination
of antibody heavy and light chains while the improved
methodsshowednoantibodycontamination.Inaddition,
several protein complexes were precipitated showing that
the beneﬁts of antibody-coupled resins extend to co-IP
applications as well.
MATERIALS AND METHODS
Materials
Antibodies. Mouse monoclonal anti-T7-tag anti-
body was purchased from Novagen, Inc (Madison, Wis).
The anti-MDM2 monoclonal antibody was bought from
Oncogene Research Products (Boston, Mass). The mouse
monoclonal antibody to 20S proteasome subunit α6w a s
purchased from Aﬃnity Research Products Ltd (Exeter,
UK). The polyclonal goat anti-GFP (green ﬂuorescent
protein) antibody was procured from Pierce Chemical Co
(Pierce, Rockford, Ill). During the antibody immobiliza-
tion processes, all centrifugation steps were performed at
80 ×g for 1 minute.
Plasmid DNAs. Plasmid DNA, pGEM-Hsp53, and
pGEM-HsMDM2 were kindly provided by Dr Arthur
Haas (Medical College of Wisconsin, Milwaukee, Wis),
and pET-T7-tag-Max and pET-c-Myc were a gift from Dr
Kent Wilcox (Medical College of Wisconsin).
SDS-PAGE. All precast SDS-PAGE gels utilized
in our experiments were the Novex brand (Invitro-
gen, Carlsbad, Calif). Standard electrophoresis condi-
tions recommended by the gel manufacturer were em-
ployed. Prestained protein molecular weight marker
(BlueRanger) was obtained from Pierce.
Reagents. For reagents and supplies which are not
described herein the vendor was Pierce.
Cross-linkingantibodiestoproteinGagarose
Protein G agarose (Pierce) was dispensed into a spin
column and washed 2–3 times with modiﬁed Dulbecco’s
phosphate-buﬀered saline (PBS, 8mM Na2PO3,2 m M2003:5 (2003) Detection of Protein-Protein Interaction 293
K2PO3, 140mM NaCl, 10mM KCl, pH 7.4). A 100–200-
µg aliquot of monoclonal or polyclonal antibody was in-
cubated with 400-µL protein G agarose (50% slurry) for
one hour at room temperature (RT). After the unbound
antibodies were washed away, antibody-bound protein G
agarose was resuspended in 400-µL modiﬁed Dulbecco’s
PBS, and 0.1mL of 13mg/mL DSS cross-linker freshly
prepared in dimethyl sulfoxide (DMSO) was added. The
cross-linking reaction was performed at RT for one hour.
The excess DSS was removed by washing the resin 4 times
with 400-µL of Tris-buﬀered saline (TBS, 25mM Tris,
150mM NaCl, pH 7.2), 4 times with 0.1M glycine (pH
2.8)toremovefreeantibody,andﬁnally3timeswithTBS.
The cross-linking eﬃciency was evaluated by A280.T h e
antibody-protein G agarose was stored as 50% slurry at
4◦C.
Couplingofantibodiestoagaroseresin
Coupling of antibodies to agarose resin was per-
formed using AminoLink Plus Coupling Gel (Pierce) in a
spin column. Brieﬂy, coupling gel was washed twice with
PBS (100mM Na2PO3, 150mM NaCl, pH 7.2). Aﬃnity-
puriﬁed antibody diluted in PBS containing 50mM
sodium cyanoborohydride was added to the resin and the
mixturewasinvertedatRTfor4hoursat1-hourintervals.
The ﬂow-through was spun out and the resin was washed
once with PBS to remove any uncoupled antibody. A 30-
minuteincubationwith1MTris-HCl,pH7.4,and50mM
sodium cyanoborohydride blocked the remaining sites on
theresin.Theresinwaswashed6timeswith1MNaCland
equilibrated in PBS containing 0.02% sodium azide for
storage at 4◦C. The ﬂow-through and the ﬁrst wash were
evaluated by A280 to determine the coupling eﬃciency.
Invitrotranscription/translation
The TNT T7/Sp6-Coupled Reticulocyte Lysate System
(Promega Corp, Madison, WI) was used for the in vitro
synthesis of 35S-labeled proteins directly from DNA tem-
plates containing T7 or SP6 RNA polymerase promoters.
The DNAtemplate (typically1µg)wasincubatedwiththe
transcription/translation mix in a total volume of 50µL
at 30◦C for 90 minutes. The synthesized protein products
were analyzed by SDS-PAGE and visualized by autoradio-
graphy.
Coimmunoprecipitation
Co-IPof20Sproteasomecomplexwithmouse
monoclonalantibodyto20Sproteasomesubunitα6
A 100-µL aliquot of mouse monoclonal anti-α6 (100–
1000µg) was cross-linked onto protein G agarose (100-
µL of settled resin) (see above procedure). Three ﬂasks
(75cm2) of 80% conﬂuent HeLa cells (∼ 5 × 107 cells)
were lysed in 3mL of M-PER mammalian lysis buﬀer
(Pierce). The cell lysate was then diluted in an equal vol-
umeofmodiﬁedDulbecco’sPBSandpreclearedwith100-
µL protein G resin for 1 hour at 4◦C with rotation. The
immunoprecipitationwasperformedovernightat4◦Cus-
ing 100-µL of the antibody-protein G resin (settled resin).
The resin was washed three times with 400µLo fT B S ,a n d
the protein complexes were eluted three times with 100-
µL 0.1M glycine (pH 2.8). Elutions were pooled and con-
centrated using Ultrafree-0.5 centrifugal ﬁltration devices
(Millipore, Bedford, Mass). SDS-PAGE (12% gel) and sil-
ver staining [13] were carried out for protein detection.
For comparison, traditional IP was performed using the
sameconditionswithoutcross-linkingtheantibodytothe
protein G resin.
To demonstrate the antibody speciﬁcity, HeLa cell
lysate (30µL) was separated by 12% SDS-PAGE and
transferred onto nitrocellulose membrane. The blot was
probed with 1µg/mL mouse monoclonal antibody to 20S
proteasome subunit α6 and detected with SuperSignal
West Pico chemiluminescent substrate (Pierce).
Co-IPofc-MycandT7-taggedMaxwithmouse
monoclonalantibodytoT7-tag
Two hundred micrograms of mouse anti-T7 tag anti-
body were cross-linked to protein G agarose (200µLs e t -
tled resin). Plasmid DNA pET-T7-tag-Max and pET-c-
Mycwereusedfortheinvitrosynthesisof 35S-labeledpro-
teins (see the procedures above). Equal amounts of 35S-
labeled T7-tagged Max and c-Myc (5µL) were incubated
together for 30 minutes at 30◦C. This mixture was added
to a spin column which contained antibody-protein G
agarose (100-µL of settled resin) in 400-µL modiﬁed Dul-
becco’s PBS. The co-IP was carried out at 4◦Cf o r2
hours with constant rotation. The resin was washed four
times with 400-µL TBS and proteins were eluted three
times with 0.1M glycine (pH 2.8) and concentrated. The
eluted protein complexes were resolved on 4–20% SDS-
PAGE. The gel was washed in Milli-Q water for 5 min-
utes, soaked in Amplify (Amersham Biosciences, Piscat-
away, NJ) for 15–30 minutes, dried, and exposed to Ko-
dak MS ﬁlm with intensifying screens (Kodak, Rochester,
NY) at −70◦C overnight. Luciferase (35S-labeled) was in-
cubated with T7-tagged Max as a negative control.
Co-IPofhumanp53andMDM2withmousemonoclonal
antibodytohumanMDM2
Plasmid DNA pGEM-Hsp53 and pGEM-HsMDM2
were used for the in vitro synthesis of 35S-labeled pro-
teins (see the procedure above). One hundred micro-
grams of anti-human MDM2 antibody were coupled to
200µL agarose using the antibody coupling method (see
the procedure above). Equal amounts of 35S-labeled hu-
m a np 5 3a n dM D M 2( 4 µL) were incubated together
for 30 minutes at 30◦C. This mixture was added to the
antibody-coupled agarose (60µL settled resin) in 200µL
modiﬁed Dulbecco’s PBS with protease inhibitors (Roche
Molecular Biochemicals, Indianapolis, Ind) and rotated
for 2 hours at 4◦C. The resin was then washed four
times with TBS and proteins were eluted three times with
0.1M glycine (pH 2.8) and concentrated. The eluted pro-
tein complexes were resolved by 4–12% SDS-PAGE and294 M. Walid Qoronﬂeh et al 2003:5 (2003)
detected with autoradiography. Luciferase (35S-labeled)
was incubated with MDM2 as a negative control.
Immunoprecipitation
Ec o l iBL21 cells (Novagen) containing 6×His-tagged
GFP plasmid were induced and lysed with B-PER bacte-
rial protein extraction reagent (Pierce). The 6×His-GFP
protein was partially puriﬁed using nickel resin (Pierce).
Anti-GFP antibody (130µg) was coupled onto Amino-
Link Plus Coupling Gel, cross-linked to protein G agarose
(see above procedures), or just mixed with protein G
agarose (all used 100-µL of settled resin). The 6×His-GFP
fusion protein (135µg) puriﬁed with nickel resin was
mixed separately with the three antibody resins in 100-
µL modiﬁed Dulbecco’s PBS in spin columns. The IP was
carried out at 4◦C for one hour with rotation. The resin-
bound antigen was washed three times with 400-µLT B S ,
and the bound antigen was eluted three times with 100-
µL of 0.1M glycine (pH 2.8). One ﬁfth of each elution
fraction was resolved on 12% SDS-PAGE under reducing
conditions and detected by Coomassie staining.
RESULTS AND DISCUSSION
Antibodyconjugationchemistry
The two novel procedures for antibody immobiliza-
tioncombinelinkerandresinchromatographytechniques
to generate either a cross-linked or coupled antibody ac-
tivated support. Chemical reactions in the antibody im-
mobilization process are described in Scheme 1.F o rf u r -
ther details of the bioconjugate chemistry, see [14, 15].
The chemistry of conjugation is brieﬂy discussed below.
The scheme also depicts a representation of the antibody-
bound resin for the two developed methods.
Cross-linkedantibodymethodandco-IPapplications
In the antibody cross-linked method, DSS is used to
covalently link the Fc portion of the antibody to the pro-
tein G or protein A agarose, generating a reusable an-
tibody support. DSS is a water-insoluble, noncleavable,
homobifunctional N-hydroxysuccinimidyl (NHS) ester
cross-linker [14, 15]. This cross-linker is widely used for
conjugating radiolabeled ligands to cell surface receptors
[16]. Accessible α-amine groups present on the N-termini
of peptides and proteins react with NHS-esters. However,
α-amines are seldom available on a protein, so the reac-
tion with side chains of amino acids becomes important.
While ﬁve amino acids contain amine groups in their side
chains, only the ε-amine of lysine reacts signiﬁcantly with
NHS-ester. A phosphate-buﬀered system was chosen for
our coupling buﬀer since any amine groups present in the
buﬀer would quench the reaction. DSS was dissolved in
DMSO at a concentration of 13mg/mL and used at a ﬁ-
nal concentrationof 2.6mg/mL. Becauseit contains apri-
mary amine, TBS was used as a blocking reagent and a
washing buﬀer after the cross-linking reaction was com-
pleted. Glycine at pH 2.8 was used to remove any free an-
tibodyafterthecross-linkingstepandtoelutetheantigen.
The average cross-linking eﬃciency was over 80% (data is
not shown).
Co-IP of proteins from cellular extracts is the most
convincing evidence that two or more proteins physi-
cally interact with each other. The 26S proteasome is a
key enzyme in the ubiquitin/ATP-dependent pathway of
protein degradation [17, 18]. The catalytic core of this
unusually large complex (Mr ∼ 700,000) is formed by
the 20S proteasome, a barrel-shaped structure comprised
of four rings each containing seven subunits, α7β7β7α7
[19, 20]. The fourteen diﬀerent subunits of mammalian
20S proteasome have molecular weights ranging from 18
to 33kd [21]. The α6 subunit is located on the outer rings
of the 20S proteasome [19]. The mouse monoclonal an-
tibody to human 20S proteasome subunit α6 recognizes
a 33-kd band on a Western blot of total HeLa cell lysate
(Figure 1). The antisubunit α6 antibody was cross-linked
to protein G agarose and used to coimmunoprecipitate
the whole 20S proteasome complex from HeLa cell lysate.
The eluted protein complex contains a series of proteins
ranging from 18 to 33kd, which is the typical pattern of
20S proteasome subunits (Figure 1a). The higher molecu-
lar weight proteins ranging from 45 to 100kd (Figure 1a,
lane 2) are the regulatory subunits of the 26S proteasome
complex which were coimmunoprecipitated with the cat-
alytic core complex [22]. As a comparison, a co-IP with
the traditional method (non-cross-linked antibody) was
performed using the same conditions. Although only one
sixth of the total eluent was analyzed on SDS-PAGE, a
strong contamination of antibody heavy and light chains
was observed (Figure 1b). This result demonstrates that
the cross-linked antibody can eﬃciently coimmunopre-
cipitate a large protein complex and eliminate the an-
tibody contamination. Therefore, this method could be
scaled up to aﬃnity purify protein complexes for down-
stream assays and protein characterization studies.
In vitro binding and co-IP assays are very useful when
studying the interactions of proteins that become com-
plex only at a certain point in the cell cycle or of a subset
of proteins belonging to a larger protein complex [22, 23].
Co-IP can also be used to conﬁrm protein-protein inter-
action results from an in vivo yeast two-hybrid screen [8].
Maxandc-Mycareapairofinteractingproteinsthatform
heterodimers to regulate the transcription of genes which
have been shown to contribute to carcinogenesis [24]. In
this experiment, 35S-labeled Max (T7-tagged) and c-Myc
were translated in vitro in the presence of L-[35S] me-
thionine using a rabbit reticulocyte lysate. The two sep-
arately synthesized 35S-labeled proteins were incubated at
30◦C for 30 minutes. The anti-T7 tag antibody was cross-
linkedtoproteinGagaroseandusedtocoimmunoprecip-
itate T7-tagged Max and c-Myc. Luciferase was used as a
negative control for T7-tagged Max. Figure 2 shows that
c-Myc can be coimmunoprecipitated with Max, whereas
luciferase does not coimmunoprecipitate with Max. The
entire co-IP experiment was performed in a single spin
column, which limited contamination of radioactive2003:5 (2003) Detection of Protein-Protein Interaction 295
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Figure 1. Comparison of co-IP using antibody cross-linked protein G agarose and non-cross-linked antibody with protein G agarose.
Mouse monoclonal antiproteasome subunit α6 antibody (100-µL) and 100-µL protein G resin were used for both co-IPs. HeLa cell
(∼ 5 × 107 cells) lysate was precleared with protein G agarose and co-IP was performed at 4◦C overnight. (a) Co-IP of 20S protea-
some complex using antisubunit α6 antibody cross-linked protein G agarose. The eluted proteasome complex was concentrated and
separated on 12% SDS-PAGE and silver stained. Lane M, BlueRanger prestained protein molecular weight marker mix; lane 1, crude
HeLa cell lysate; lane 2, elutions 1 and 2; lane 3, elutions 3 and 4. (b) Co-IP of 20S proteasome complex using traditional antisubunit
α6 antibody with protein G agarose. One sixth of total eluted proteasome-antibody complex was separated on 12% SDS-PAGE and
silver stained. (c) Immunoblot detection of 20S proteasome subunit α6 in crude HeLa cell lysate using anti-α6 antibody.
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Max c-Myc Luc c-Myc Luc
Max Max Labeled proteins
Co-IP
Figure 2.CoimmunoprecipitationofT7-taggedMaxandc-Myc
using anti-T7 tag antibody cross-linked protein G agarose. Max
(T7-tagged), c-Myc, and luciferase were in vitro translated and
35S-labeled (lanes 1, 2, and 3) using the TNT-Coupled Retic-
ulocyte Lysate System. Before co-IP, Max and c-Myc, and Max
and luciferase were mixed proportionally and incubated at 30◦C
for 1 hour. Co-IPs were carried out with anti-T7 tag antibody
cross-linked protein G agarose at 4◦C for 2 hours (lanes 4 and
5) and the eluted protein complexes were separated on 4–20%
SDS-PAGE. The 35S-labeled proteins were detected by autora-
diography. Star (∗): degradation product of c-Myc.
material, and prevented the loss of resin between the
washes, thereby enhancing the recovery [25]. As little as
25µL of antibody-protein G agarose per sample was used
up to ﬁve times without detectable loss of the activity.
Thisadvantagecouldbeveryusefulforconﬁrminginvivo
yeast two-hybrid screening results because the protein G
agarosecross-linkedtoanantibodyagainstthe“bait”pro-
tein can be used repeatedly to conﬁrm the interaction
between the “bait” protein and each “prey” protein. We
also have used protein G agarose cross-linked with the
c-Myc tag antibody to successfully coimmunoprecipitate
SV40 large-T antigen with c-Myc-tagged p53 (data is not
shown).
Although cross-linking antibody to protein G or pro-
tein A agarose is a good approach to immobilize the an-
tibodies in the correct orientation, the cross-linking eﬃ-
ciency and speciﬁcity varied depending upon the concen-
trations of antibody, protein G agarose, and cross-linking
reagent. Binding capacity after cross-linking also varied
from antibody to antibody. The drop in binding capacity
could be caused by a change in conformation when cross-
linking occurs on the surface of the antibody molecule or
when cross-linking occurs within the binding sites (see
data below). Therefore, optimal DSS and antibody con-
centrations need to be determined empirically for each
antibody. This led us to expand our investigation for a
more universal method of antibody attachment with im-
proved preservation of antibody binding activity.
Antibody-coupledmethodandco-IPapplications
The antibody-coupled procedure utilizes reductive
amination to directly link the antibody to the agarose296 M. Walid Qoronﬂeh et al 2003:5 (2003)
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Figure3.Couplingofmammalianandavianantibodies.(a)An-
tibody from various species (200µg) was coupled to 200µLo f
coupling gel (settled gel) at 1-hour intervals for 4 hours at RT.
For the chicken antibody, 500µL was used. (b) Normal chicken
IgY antibody (100–750µg) was coupled to 200µL of coupling gel
(settled gel) at 1-hour intervals for 4 hours at RT.
bead. The coupling resin is provided in an activated state
containing aldehyde groups formed by mild oxidation of
adjacentdiolsusingsodiummeta-periodate[14].Primary
and secondary amine groups on the antibody react with
the aldehydes to form Schiﬀ bases that are then reduced
by sodium cyanoborohydride to form secondary and ter-
tiary amine linkages [14]. Since this procedure links the
antibody to the resin in every direction, not all anti-
body molecules will present an active orientation. Typ-
p53
Luciferase
MDM2
MDM2 p53 Luc p53 Luc
MDM2 MDM2
Labeled proteins Co-IP
Figure 4. Coimmunoprecipitation of p53 and MDM2 using
anti-MDM2 antibody-coupled agarose. MDM2, p53, and lu-
ciferase were in vitro translated and 35S-labeled using TNT-
Coupled Reticulocyte Lysate System. p53 and MDM2 were com-
bined and incubated at 30◦C for 30 minutes. Co-IP was per-
formed at 4◦C for 2 hours with 60µL anti-MDM2 antibody-
coupled agarose. Luciferase was used as a negative control pro-
tein to incubate with MDM2. Eluted proteins were resolved on
4–12% SDS-PAGE and visualized by autoradiography.
ical coupling eﬃciencies for various species of antibod-
ies are shown in Figure 3a. The coupling eﬃciencies were
determined by spectrophotometric analysis of antibody
solutions before and after coupling. On average, 88 per-
cent of the antibody was coupled in 4 hours when using
200µg of antibody and 200µL of settled resin. Scalabil-
ity was demonstrated when immobilization using 50 and
100-µL of settled coupling resin yielded comparable cou-
pling eﬃciencies (data is not shown). All species of anti-
body exhibited the same relationship with respect to time
and coupling. Therefore, this method is not limited to an-
tibody species that only bind strongly to protein G or pro-
tein A. Figure 3b illustrates the relationship between pro-
tein concentration and the rate of the coupling reaction.
As expected, the rate of coupling increases with increased
protein concentration. These results show that this is a
universal technique with no need to optimize for each an-
tibody.
MDM2 oncoprotein plays a central role in the regula-
tion of p53 tumor suppressor protein [26, 27, 28]. MDM2
binds to p53 and blocks its activity as a tumor suppres-
sor and promotes its degradation in many tumor cells
[6, 29]. In our experiment, human p53 and MDM2 genes
were transcribed/translated and 35S-labeled in a reticulo-
cyte lysate. The co-IP result using coupled anti-MDM2
antibody shows that MDM2 interacts with p53 but not
luciferase (Figure 4). We have used as little as 20µL of the
antibody-coupled resin and have reused the resin up to
ﬁve times without obvious loss of activity.
Bindingcapacityofantibody-coupledresin
orantibodycross-linkedresin
The antibody cross-linked and antibody-coupled pro-
cedures eliminate the contamination problem by pre-
venting the antibody from co-eluting with the antigen.2003:5 (2003) Detection of Protein-Protein Interaction 297
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Figure 5.ComparisonofIPusingantibodycross-linkedproteinGagarose,antibody-coupledagarose,andnon-cross-linkedantibody
with protein G agarose. In each case, 130µgo fa ﬃnity-puriﬁed goat anti-GFP antibody was used with 100-µL of settled protein G gel
or coupling gel. IP was performed using 135µg of partially puriﬁed GFP. Ten percent of the elution volume was electrophoresed on
a 12% polyacrylamide reducing gel and stained with Coomassie. Lane M, BlueRanger molecular weight marker; lanes 1–3 elutions
from diﬀerent antibody immobilization methods.
Another beneﬁt to both methods is that the antibody-
resin is reusable, thereby conserving valuable antibody.
We compared the traditional, antibody cross-linked and
antibody-coupled procedures to evaluate the relative
amount of antigen recovered using the same amount of
goat anti-GFP antibody (Figure 5). Under these condi-
tions, a signiﬁcant increase in recovered antigen is seen
when using the antibody-coupled procedure versus the
antibody cross-linked method. Although the traditional
method yielded a greater quantity of antigen, the pres-
ence of antibody light chains in the eluent distorted the
recovered GFP band, since they have comparable molec-
ular weights.
CONCLUSIONS
We have developed two methods to immunoprecipi-
tate and coimmunoprecipitate proteins that eliminate an-
tibody contamination. The ﬁrst method properly orients
theantibodyforantigenrecognitionbybindingitsFcpor-
tion to protein A or protein G resin. Subsequently, the
antibody is cross-linked to the resin to prevent leaching
into the eluent. The second method achieves the same
goalyetisuniversalforallantibody classesandspeciesbe-
cause it couples the antibody directly to the resin matrix.
BothmethodsgivecomparableresultstotraditionalIPal-
though overall antigen-binding eﬃciency is not always as
high as with traditional IP. The precipitated proteins from
ourIPandco-IPmethodscanbeeasilydetectedandchar-
a c t e r i z e di nd o w n s t r e a ma p p l i c a t i o n ss u c ha sm a s ss p e c -
trometry or enzymatic assays. Furthermore, the stabilized
antibody-linked resin fromeither techniquecan beregen-
erated and reused multiple times thereby conserving pre-
cious antibody samples.
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